Everforth Inc insider trading
Every open-market purchase and sale by Everforth Inc's officers, directors and largest shareholders since November 4, 2021, and what the share price did next.
| Date | Insider | Trade | Shares | Price | Value | 1M after | 3M after | 6M after |
|---|
Does following Everforth Inc’s insiders pay?
From March 3, 2010 to April 29, 2026, 29 insiders reported 27 open-market purchases and 221 sales not made under a pre-set plan in Everforth Inc. Twelve months after each purchase was reported, the shares were +15.3% against the S&P 500 on average (median −18.7%), over 13 purchases with a full year of prices; 39% beat the index. After sales, the shares moved +7.5% against the index over 12 months (a negative figure means selling was the right call). That rests on fewer than 20 purchases, too few to read much into. Buying each purchase the day after it was reported, an equal amount each, held 12 months or until that insider reported a sale, would have turned $10,000 on May 10, 2010 into $222,386 by November 2, 2026, +20.8% a year. It held shares 39% of the time; the S&P 500 on those same days, with Treasury bills otherwise, made $43,691 (+9.4% a year), and held throughout $87,121 (+14.1%).
| Insider | Role | Purchases | 12 months after their purchases | Beat the S&P 500 | Sales | 12 months after their sales | Latest report |
|---|---|---|---|---|---|---|---|
| Dameris Peter T | Chief Executive Officer | 1 | −24.5% (1) | 0% | 33 | +23.7% (33) | November 20, 2018 |
| Sheridan Edwin A. | Director | 1 | −18.7% (1) | 0% | 27 | +8.2% (27) | March 8, 2024 |
| Blazer Randolph C | President | 0 | — | — | 24 | −5.7% (24) | October 25, 2024 |
| Holman Jonathan S | Director | 1 | — | — | 18 | +20.0% (18) | April 27, 2026 |
| Hanson Theodore S. | Chief Executive Officer | 1 | — | — | 15 | −0.9% (15) | April 27, 2026 |
| Callaghan Brian J. | Director | 2 | −17.8% (1) | 0% | 12 | +14.9% (12) | April 27, 2026 |
| Mcgowan Michael | COO, OAI; Pres, OGR | 3 | +41.8% (3) | 67% | 11 | +15.9% (11) | June 12, 2017 |
| Kittrell Marty R | Director | 1 | +72.7% (1) | 100% | 11 | −11.4% (11) | April 30, 2024 |
| Jones Jeremy M | Director | 1 | −34.6% (1) | 0% | 10 | +0.8% (10) | February 26, 2021 |
| Brill James L | SVP, CAO & Treasurer | 0 | — | — | 9 | +8.3% (9) | February 25, 2015 |
| Mcgrath Emmett | Pres, Life Sciences &Allied HC | 1 | +32.7% (1) | 100% | 7 | +24.1% (7) | December 6, 2013 |
| Painter Jennifer Hankes | SVP, Chief Legal Officer | 2 | −18.7% (1) | 0% | 6 | −9.4% (6) | April 27, 2026 |
| Brock William E | Director | 0 | — | — | 7 | +5.5% (7) | April 30, 2019 |
| Gibson Christina | V.P., Finance and Controller | 0 | — | — | 7 | +29.3% (7) | September 10, 2013 |
| Pierce Edward L | Exec VP, CFO | 0 | — | — | 7 | −0.6% (7) | November 8, 2021 |
| Matin Arshad | Director | 1 | — | — | 5 | −25.4% (5) | April 27, 2026 |
| Veatch Jeffrey E. | Other | 0 | — | — | 4 | −5.5% (4) | December 8, 2016 |
| Dyer Joseph Wendell | Director | 3 | −19.7% (1) | 0% | 0 | — | April 29, 2026 |
| Frantz Mark A. | Director | 1 | — | — | 1 | −17.6% (1) | April 27, 2026 |
| Hoffman-Abby Kathryn | President, Nurse Travel | 0 | — | — | 2 | +46.4% (2) | December 12, 2012 |
| Iyer Sadasivam | President | 2 | — | — | 0 | — | April 28, 2026 |
| Lindstrom Carol | Director | 0 | — | — | 2 | −65.7% (2) | October 25, 2024 |
| Rutherford Christian | President of Vista Staffing | 0 | — | — | 2 | −6.6% (2) | April 9, 2014 |
| Wilson George H | President, ECS | 2 | +51.0% (2) | 50% | 0 | — | March 11, 2020 |
| Cunningham Rose | Chief Accounting Officer | 1 | — | — | 0 | — | April 28, 2026 |
| Hawthorne Maria R | Director | 1 | — | — | 0 | — | April 27, 2026 |
| Joliet Mariel A | Director | 0 | — | — | 1 | +0.9% (1) | August 10, 2021 |
| Obermaier Patricia L | Director | 1 | — | — | 0 | — | April 27, 2026 |
| Perry Marie | EVP, Chief Financial Officer | 1 | — | — | 0 | — | April 27, 2026 |
When several insiders traded Everforth Inc
Months when 2 or more insiders became net buyers, or 3 or more net sellers, of Everforth Inc in reports dated in the 91 days before the month end, and how the stock did against the S&P 500 from that month end. After the 2 buying crowds with six months of prices, it averaged +22.0% against the index. After 17 selling crowds, −1.7%. One company's history is too short to judge by; the test across every company is the better guide.
| Month | Crowd | 3 months on, vs S&P 500 | 6 months | 12 months |
|---|---|---|---|---|
| April 30, 2026 | 12 buying | +30.6% | +67.8% | not yet |
| September 30, 2024 | 3 selling | −13.3% | −30.5% | −66.7% |
| December 29, 2023 | 3 selling | −4.6% | −25.4% | −38.2% |
| August 31, 2021 | 5 selling | +7.2% | +0.4% | −2.6% |
| March 31, 2021 | 3 selling | −6.8% | +10.5% | +5.2% |
| June 30, 2020 | 5 selling | −12.1% | +4.2% | +4.5% |
| November 30, 2018 | 6 buying | −10.7% | −23.7% | −17.9% |
| August 31, 2018 | 5 selling | −20.6% | −28.8% | −35.4% |
| March 29, 2018 | 3 selling | −9.6% | −16.0% | −32.1% |
| November 30, 2017 | 8 selling | +19.0% | +21.1% | +2.4% |
| March 31, 2017 | 5 selling | +8.5% | +3.0% | +57.1% |
| November 30, 2016 | 3 selling | +5.0% | +18.6% | +32.2% |